New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
18:00 EDTBONEBacterin reports preliminary Q2 revenue $8.75M-$8.85M, consensus $8.93M
The company sees preliminary Q2 operating loss ($1.5M)-($1.4M). The company sees preliminary Q2 EBITDA of ($800K)-($900K). Gross margin for Q2 is expected to be 61%-63%.
News For BONE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
19:03 EDTBONEBacterin to acquire X-spine Systems, change name of new company to Xtant Medical
Bacterin announced that it intends to purchase the outstanding shares of privately held X-spine Systems in exchange for approximately 4.24M shares of Bacterin common stock and approximately $60M in cash, subject to customary working capital adjustments, and including the extinguishment of approximately $13M of X-spine debt. The transaction will position the combined company as a comprehensive supplier for spine surgery procedures that offers both hardware and biologics through a more substantial national distribution footprint. Concurrent with the closing, Bacterin International Holdings, Inc. will change its name to Xtant Medical Holdings, Inc. Dr. David Kirschman, currently X-spine CEO, will join the management team and serve as EVP and Chief Scientific Officer of Xtant Medical Holdings, Inc. He will also be president of X-spine Systems, the hardware subsidiary. Dr. Kirschman will also be appointed to the Xtant Medical Holdings, Inc. board.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use